{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T05:45:15Z","timestamp":1696311915979},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2007]]},"DOI":"10.2169\/naika.96.2046","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T22:31:47Z","timestamp":1343773907000},"page":"2046-2053","source":"Crossref","is-referenced-by-count":1,"title":["16. Immunoglobulin Therapy for Neurologic Diseases"],"prefix":"10.2169","volume":"96","author":[{"given":"Kyouichi","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dalakas MC: High-dose intravenous immunoglobulin and serum viscosity. Risk of precipitating thromboembolic events. Neurology 44: 223-236, 1995.","DOI":"10.1212\/WNL.44.2.223"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Silbert PL, et al: Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis. Neurology 42: 257-258, 1992.","DOI":"10.1212\/WNL.42.1.257"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sekul EA, et al: Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med 121: 259-262, 1994.","DOI":"10.7326\/0003-4819-121-4-199408150-00004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kleyweg RP, et al: Treatment of Guillain-Barr&eacute; syndrome with high-dose gammaglobulin. Neurology 38: 1639-1641, 1988.","DOI":"10.1212\/WNL.38.10.1639"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Van der Meche FGA, et al: A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr&eacute; syndrome. N Engl J Med 326: 1123-1129, 1992.","DOI":"10.1056\/NEJM199204233261705"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Brill V, et al: Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barr&eacute; syndrome. Neurology 46: 100-103, 1996.","DOI":"10.1212\/WNL.46.1.100"},{"key":"7"},{"key":"8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hughes RAC, et al: Practice parameter: Immnotherapy for Guillain-Barr&eacute; syndrome. Report of the quality standards subcommittee of American Academy of Neurology. Neurology 61: 736-740, 2003.","DOI":"10.1212\/WNL.61.6.736"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yuki N, et al: Clinical features and response to treatment in Guillain-Barr&eacute; syndrome associated with antibody to GM1b ganglioside. Ann Neurol 47: 314-321, 2000.","DOI":"10.1002\/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kuwabara S, et al: Intravenous immunoglobulin therapy for Guillain-Barr&eacute; syndrome with IgG anti-GM1 antibody. Muscle Nerve 24: 54-58, 2001.","DOI":"10.1002\/1097-4598(200101)24:1<54::AID-MUS6>3.0.CO;2-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Plasma Exchange\/Sandoglobulin Guillain-Barr&eacute; Syndrome Trial Group: randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr&eacute; syndrome. Lancet 349: 225-230, 1997.","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hughes RAC, et al: Controlled trial of prednisolone in acute polyneuropathy. Lancet 2 (8093): 750-753, 1978.","DOI":"10.1016\/S0140-6736(78)92644-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Guillain-Barr&eacute; syndrome steroid trial group: double-blind trial of intravenous methylpredonisolone in Guillian-Barr&eacute; syndrome. Lancet 341: 586-590, 1993.","DOI":"10.1016\/0140-6736(93)90351-G"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) The Dutch Guillain-Barr&eacute; Study Group: Treatment of Guillain-Barr&eacute; syndrome with high-dose immunoglobulins combined with methylprednisolone: a pilot study. Ann Neurol 35: 749-752, 1994.","DOI":"10.1002\/ana.410350618"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Oomes PG, et al: Liver function disturbances in Guillain-Barr&eacute; syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barr&eacute; Study Group. Neurology 46: 96-100, 1996.","DOI":"10.1212\/WNL.46.1.96"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Raphael JC, et al: Intravenous immune globulins in patients with Guillain-Barr&eacute; syndome and contraindications to plasma exchange; 3 days versus 6 days. J Neurol Neurosurg Psychiatry 71: 235-238, 2001.","DOI":"10.1136\/jnnp.71.2.235"},{"key":"18"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yamada H, et al: Massive intravenous immunoglobulin treatment in pregnancy complicated by Guillain-Barr&eacute; syndrome. Eur J Obstet Gynecol Reprod Biol 97: 101-104, 2001.","DOI":"10.1016\/S0301-2115(00)00481-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Chan LY, et al: Guillain-Barr&eacute; syndrome in pregnancy. Acta Obstet Gynecol Scand 83: 319-325, 2004.","DOI":"10.1080\/j.0001-6349.2004.0473.x"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/96\/9\/96_2046\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:40:17Z","timestamp":1621442417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/96\/9\/96_2046\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.96.2046","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}